A systematic review of non-motor symptoms in atypical parkinsonian syndromes
Objective: We wanted to systematically analyse the repertoire of NMS in patients with progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD) and…Voluntary saccades slowness in parkinson disease and multiple system atrophy
Objective: This study aimed to explore and compare visually-guided and memory-guided saccades in PD and MSA. Background: Parkinson’s disease (PD) produced oculomotor alterations such as…Emotion Recognition in Multiple System Atrophy – an Eye-Tracking Study
Objective: To get better insights into emotion processing in patients with MSA-P compared to healthy controls (HCs) by using two different Eye-Tracking paradigms. Background: MSA…Wearable Sensors for Quantitative Motor Assessments in Multiple System Atrophy
Objective: To determine the utility of quantitative wearable sensors in Multiple system atrophy (MSA). Background: Symptoms of MSA include parkinsonism, ataxia, and/or failure of the…Cognitive assessment in a Greek cohort of Multiple System Atrophy patients.
Objective: The aim of the present study was to assess cognitive dysfunction in a Multiple System Atrophy (MSA) cohort and possible differences between disorder subtypes…An Unusual Case of Multiple Systems Atrophy with Long Disease Duration, Severe Gliosis, and Scant Synuclein Pathology
Objective: To describe a pathologically unusual case of Multiple systems atrophy (MSA) with severe widespread gliosis and neuronal loss with scant alpha-synuclein (aSyn) pathology. Background:…Laryngeal Electromyography Findings in patients with Multiple System Atrophy
Objective: to systematically evaluate laryngeal electromyography findings, correlate them to laryngeal movement disorders assessed by a systematic task-protocol performed during FEES and clinical laryngeal symptoms.…Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson’s Disease
Objective: We aimed to investigate the plasma short-chain fatty acids (SCFAs) in multiple system atrophy (MSA) patients and to identify the potential differential diagnostic ability.…The Implications of Pyramidal Signs in Multiple System Atrophy
Objective: To determine pyramidal signs in multiple system atrophy (MSA) and the associations with other clinical characteristics. Background: The clinical manifestations of MSA are comprised…Sexual dysfunction in female patients with Multiple System Atrophy
Objective: To characterize sexual dysfunction in female patients with Multiple System Atrophy (MSA). Background: The diagnosis of probable MSA relies on the presence of parkinsonian…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 23
- Next Page »